Skip to content
Disclosery

ORBIMED ADVISORS LLC: ADCT position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on ADCT, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 0 ADCT shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 0 shares
    Change vs previous 13F -1,318,026 shares

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2026-03-31
    13F 1,318,026 shares
    Change vs previous 13F -4,504,828 shares

    0.11% of the 13F portfolio, value $4,942,598.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 5,822,854 shares
    Change vs previous 13F -84,497 shares

    0.42% of the 13F portfolio, value $20,554,675.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 5,907,351 shares
    Change vs previous 13F 0 shares

    0.57% of the 13F portfolio, value $23,629,404.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 5,907,351 shares
    Change vs previous 13F -61,100 shares

    0.4% of the 13F portfolio, value $15,831,701.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 5,968,451 shares
    Change vs previous 13F 0 shares

    0.2% of the 13F portfolio, value $8,415,516.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 5,968,451 shares
    Change vs previous 13F +1,434,650 shares

    0.25% of the 13F portfolio, value $11,877,217.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 4,533,801 shares
    Change vs previous 13F not available

    0.26% of the 13F portfolio, value $14,281,473.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).